companydata.dkcompanydata.dk

AJ Vaccines A/S: Financial statements 2024

CVR: 37911143

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 412,969,000 and a net result of DKK -807,117,000 compared with DKK -242,974,000 the year before. That is a decrease of 11.9% compared with the year before. The profit margin was -195.4%. Equity in the 2024 report amounted to DKK 501,919,000. The solvency ratio was 46.1%. The company had 581 employees in the financial year.

Revenue
DKK 412,969,000
Gross Profit
DKK -587,049,000
Profit/Loss
DKK -807,117,000
Equity
DKK 501,919,000
Total Assets
DKK 1,088,929,000
Employees
581

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024413M-587M-807.1M501.9M581
2023468.9M-30.7M-243M1B577
2022421M-66M-268.1M994.7M556
2021351.9M-304M-486.4M815.9M558
2020351.6M-313.9M-450.2M1.1B702

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Tarek Sherif Ahmed Abbas Hegazy joins the board of AJ Vaccines A/SJul 23, 2024

As of July 23, 2024, Tarek Sherif Ahmed Abbas Hegazy has joined the board of directors of AJ Vaccines A/S.

Shan-E-Abbas Ashary leaves the board of AJ Vaccines A/SJul 23, 2024

As of July 23, 2024, Shan-E-Abbas Ashary has left the board of directors of AJ Vaccines A/S.

AJ Vaccines A/S: The 2023 annual report is outJul 8, 2024

AJ Vaccines A/S has published its annual report for 2023. Revenue came to DKK 468,886,000, and the net result was DKK -242,974,000.

About AJ Vaccines A/S

AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.

Source: annual report 2025, Danish Business Authority

Other financial years